NeuroMEDx technology has the potential to significantly affect and enable the treatment of debilitating diseases and to greatly reduce the costs of treatment.

NeuroMEDx has been granted three broad US patents - 7,300,449, 6,764,498, and 6,375,666 - Pending patents cover additional designs and clinical applications (i.e. depression, migraine, afib) of this platform technology.